A platform for researching healthy aging and biomarkers
Official title: The Inspire Bio-resource Research Platform for Healthy Aging
Run by University Hospital, Toulouse · NCT04224038 · Data updated 2026-11-12
This study is trying to find out how we can spot signs of aging and age-related diseases by collecting health information from people aged 30 and older over ten years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 30 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | University Hospital, Toulouse Academic / other |
| Locations | 1 site (Toulouse) |
| Status | Recruiting |
| Started | October 16, 2019 |
| Main results expected | October 16, 2031 |
| Study ends | October 31, 2033 |
| Registry record updated | November 21, 2023 |
| Trial ID | NCT04224038 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals aged 30 years or older who are affiliated with a social security scheme.
✕Probably not a fit
Patients with severe diseases that compromise life expectancy within five years may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Inspire Bio-resource Research Platform for Healthy Aging aims to create a comprehensive research platform that collects biological, clinical, and digital resources to identify markers of aging and age-related diseases. Over a span of 10 years, data and biospecimens will be gathered from participants aged 30 and older, with varying levels of functional capacity. Participants will undergo yearly data collection and will be monitored every four months through an app or phone calls by clinical nurses. This approach allows for the investigation of aging markers as declines in intrinsic capacity are detected.
Why it matters
Potential benefit: If successful, this platform could lead to the identification of key biomarkers for aging, potentially improving health outcomes for older adults.
How similar studies have gone: Other studies focusing on biomarkers of aging have shown promise, but this platform represents a novel and comprehensive approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 30 years-old or over; * Both sexes * Affiliated to a social security scheme Exclusion Criteria: * severe disease compromising life expectancy at 5 years; * Deprived of their liberty by administrative or judicial decision, or under guardianship
Where it's running
-
University Hospital Toulouse
Toulouse, France Recruiting
Study contacts
- Principal investigator: Bruno VELLAS, MD — University Hospital of Toulouse
- Study coordinator: Bruno VELLAS, MD
- Email: vellas.b@chu-toulouse.fr
- Phone: 5 61 77 70 47
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Humic and Fulvic Acid Supplement for Biological Aging and Detoxification Markers
This study tests BioToxin Binder, a humic and fulvic acid supplement, to see if it affects aging, detoxification, inflammation, and oxidative stress markers in generally healthy adults aged 40 and older.
-
Topical lavender oil to help recovery after lung resection
This study tests whether applying lavender essential oil to the skin around the surgical wound for three days after lung surgery can improve recovery and reduce pain.
-
Does THC-COOH appear in sweat after a child’s cannabis intoxication?
This study tests whether the cannabis metabolite THC-COOH can be found in sweat after a young child’s cannabis intoxication to see if hair testing is reliable for prior exposure.
-
Intensive rhythm-based dance program to improve learning skills in children with cerebral palsy
This project will try a rhythm-based intensive dance program to see if it helps children aged 6–17 with cerebral palsy improve motor learning and related skills.
-
Home-use Grasp Neuroprosthesis for helping with finger opening after stroke
This study tests a wearable grasp neuroprosthesis at home to see if it helps people who have trouble opening their hand after a stroke.
-
[18F]-DPA-714 PET to detect brain inflammation in autoimmune encephalitis
This test tries to see if [18F]-DPA-714 PET scans can detect brain inflammation in adults newly diagnosed with autoimmune encephalitis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.